Literature DB >> 25456597

A liquid chromatography-tandem mass spectrometry-based method for the simultaneous determination of hydroxy sterols and bile acids.

Clara John1, Philipp Werner2, Anna Worthmann1, Katrin Wegner2, Klaus Tödter1, Ludger Scheja1, Sascha Rohn2, Joerg Heeren3, Markus Fischer4.   

Abstract

Recently, hydroxy sterols and bile acids have gained growing interest as they are important regulators of energy homoeostasis and inflammation. The high number of different hydroxy sterols and bile acid species requires powerful analytical tools to quantify these structurally and chemically similar analytes. Here, we introduce a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based method for rapid quantification of 34 sterols (hydroxy sterols, primary, secondary bile acids as well as their taurine and glycine conjugates). Chromatographic baseline separation of isomeric hydroxy sterols and bile acids is obtained using a rugged amide embedded C18 (polar embedded) stationary phase. The current method features a simple extraction protocol validated for blood plasma, urine, gall bladder, liver, feces, and adipose tissue avoiding solid phase extraction as well as derivatization procedures. The total extraction recovery for representative analytes ranged between 58-86% in plasma, 85% in urine, 79-92% in liver, 76-98% in adipose tissue, 93-104% in feces and 62-79% in gall bladder. The validation procedure demonstrated that the calibration curves were linear over the selected concentration ranges for 97% of the analytes, with calculated coefficients of determination (R2) of greater than 0.99. A feeding study in wild type mice with a standard chow and a cholesterol-enriched Western type diet illustrated that the protocol described here provides a powerful tool to simultaneously quantify cholesterol derivatives and bile acids in metabolically active tissues and to follow the enterohepatic circulation.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bile acids; HPLC-ESI-QqQ-MS/MS; Hydroxy sterols; Polar embedded stationary phase; Sterol profiling in biological matrices lipid metabolism

Mesh:

Substances:

Year:  2014        PMID: 25456597     DOI: 10.1016/j.chroma.2014.10.064

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  14 in total

1.  Cold-induced conversion of cholesterol to bile acids in mice shapes the gut microbiome and promotes adaptive thermogenesis.

Authors:  Anna Worthmann; Clara John; Malte C Rühlemann; Miriam Baguhl; Femke-Anouska Heinsen; Nicola Schaltenberg; Markus Heine; Christian Schlein; Ioannis Evangelakos; Chieko Mineo; Markus Fischer; Maura Dandri; Claus Kremoser; Ludger Scheja; Andre Franke; Philip W Shaul; Joerg Heeren
Journal:  Nat Med       Date:  2017-06-12       Impact factor: 53.440

2.  Dietary supplementation of porcine bile acids improves laying performance, serum lipid metabolism and cecal microbiota in late-phase laying hens.

Authors:  Bowen Yang; Shimeng Huang; Guoxian Zhao; Qiugang Ma
Journal:  Anim Nutr       Date:  2022-08-14

3.  Quantification of bile acids: a mass spectrometry platform for studying gut microbe connection to metabolic diseases.

Authors:  Ibrahim Choucair; Ina Nemet; Lin Li; Margaret A Cole; Sarah M Skye; Jennifer D Kirsop; Michael A Fischbach; Valentin Gogonea; J Mark Brown; W H Wilson Tang; Stanley L Hazen
Journal:  J Lipid Res       Date:  2019-12-09       Impact factor: 5.922

4.  Faecal bile acids are natural ligands of the mouse accessory olfactory system.

Authors:  Wayne I Doyle; Jordan A Dinser; Hillary L Cansler; Xingjian Zhang; Daniel D Dinh; Natasha S Browder; Ian M Riddington; Julian P Meeks
Journal:  Nat Commun       Date:  2016-06-21       Impact factor: 14.919

5.  Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment.

Authors:  Yanyun Gu; Xiaokai Wang; Junhua Li; Yifei Zhang; Huanzi Zhong; Ruixin Liu; Dongya Zhang; Qiang Feng; Xiaoyan Xie; Jie Hong; Huahui Ren; Wei Liu; Jing Ma; Qing Su; Hongmei Zhang; Jialin Yang; Xiaoling Wang; Xinjie Zhao; Weiqiong Gu; Yufang Bi; Yongde Peng; Xiaoqiang Xu; Huihua Xia; Fang Li; Xun Xu; Huanming Yang; Guowang Xu; Lise Madsen; Karsten Kristiansen; Guang Ning; Weiqing Wang
Journal:  Nat Commun       Date:  2017-11-27       Impact factor: 14.919

6.  BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.

Authors:  Adriana Carino; Sabrina Cipriani; Silvia Marchianò; Michele Biagioli; Chiara Santorelli; Annibale Donini; Angela Zampella; Maria Chiara Monti; Stefano Fiorucci
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

7.  Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases.

Authors:  Carmen Festa; Simona De Marino; Adriana Carino; Valentina Sepe; Silvia Marchianò; Sabrina Cipriani; Francesco S Di Leva; Vittorio Limongelli; Maria C Monti; Angela Capolupo; Eleonora Distrutti; Stefano Fiorucci; Angela Zampella
Journal:  Front Pharmacol       Date:  2017-03-30       Impact factor: 5.810

Review 8.  Detection technologies and metabolic profiling of bile acids: a comprehensive review.

Authors:  Yanan Liu; Zhihui Rong; Dong Xiang; Chengliang Zhang; Dong Liu
Journal:  Lipids Health Dis       Date:  2018-05-23       Impact factor: 3.876

9.  Ilexsaponin A1 Ameliorates Diet-Induced Nonalcoholic Fatty Liver Disease by Regulating Bile Acid Metabolism in Mice.

Authors:  Wen-Wen Zhao; Meng Xiao; Xia Wu; Xiu-Wei Li; Xiao-Xi Li; Ting Zhao; Lan Yu; Xiao-Qing Chen
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

10.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-elicited effects on bile acid homeostasis: Alterations in biosynthesis, enterohepatic circulation, and microbial metabolism.

Authors:  Kelly A Fader; Rance Nault; Chen Zhang; Kazuyoshi Kumagai; Jack R Harkema; Timothy R Zacharewski
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.